These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16934134)

  • 21. A case series of drotrecogin alfa (activated) in lung transplant recipients.
    Daniels TL; Dummer JS; Bernard GR; Milstone AP
    Transplantation; 2006 Jun; 81(12):1739-42. PubMed ID: 16794542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drotrecogin alfa (recombinant human activated protein C) in severe sepsis--a New Zealand viewpoint.
    Liang J; Streat S; Torrance J; Sleigh J; Freebairn R; Ramsay M
    N Z Med J; 2003 Sep; 116(1181):U586. PubMed ID: 14581969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated protein C for severe sepsis.
    Garces K
    Issues Emerg Health Technol; 2002 Mar; (30):1-4. PubMed ID: 11985365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drotrecogin alfa (activated) in severe sepsis.
    Gayat E; Lemasle L; Payen D
    Lancet Infect Dis; 2013 Feb; 13(2):109-10. PubMed ID: 23347627
    [No Abstract]   [Full Text] [Related]  

  • 25. Drotrecogin alfa (activated) in severe sepsis.
    Janes JM; Vangerow B; Costigan TM; Macias WL
    Lancet Infect Dis; 2013 Feb; 13(2):108-9. PubMed ID: 23347626
    [No Abstract]   [Full Text] [Related]  

  • 26. Drotrecogin alfa (activated) in severe sepsis.
    Marik PE
    Lancet Infect Dis; 2013 Feb; 13(2):107. PubMed ID: 23347625
    [No Abstract]   [Full Text] [Related]  

  • 27. Drotrecogin alfa (activated) in severe sepsis.
    Poole D; Rossi C; Addis A; Livigni S; Bertolini G
    Lancet Infect Dis; 2013 Feb; 13(2):107-8. PubMed ID: 23347624
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated).
    Levi M; Levy M; Williams MD; Douglas I; Artigas A; Antonelli M; Wyncoll D; Janes J; Booth FV; Wang D; Sundin DP; Macias WL;
    Am J Respir Crit Care Med; 2007 Sep; 176(5):483-90. PubMed ID: 17556722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort.
    Payen D; Sablotzki A; Barie PS; Ramsay G; Lowry S; Williams M; Sarwat S; Northrup J; Toland P; McL Booth FV
    Surgery; 2006 Nov; 140(5):726-39. PubMed ID: 17084715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drotrecogin alfa (activated) in severe sepsis--authors' reply.
    Kalil AC; LaRosa SP
    Lancet Infect Dis; 2013 Feb; 13(2):110-1. PubMed ID: 23347628
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of drotrecogin alfa (activated) in human endotoxemia.
    Kalil AC; Coyle SM; Um JY; LaRosa SP; Turlo MA; Calvano SE; Sundin DP; Nelson DR; Lowry SF
    Shock; 2004 Mar; 21(3):222-9. PubMed ID: 14770034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis.
    De Backer D; Verdant C; Chierego M; Koch M; Gullo A; Vincent JL
    Crit Care Med; 2006 Jul; 34(7):1918-24. PubMed ID: 16715034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Exogenous activated protein C in severe sepsis].
    Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
    Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
    McLeay AM
    Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drotrecogin alfa (activated) in severe sepsis.
    Tsalis K
    Med Sci Monit; 2004 Oct; 10(10):LE19. PubMed ID: 15448603
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemorrhagic risk of drotrecogin alfa (activated) in severe sepsis].
    Perrotin D
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():16-9. PubMed ID: 15359934
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment on "Drotrecogin Alfa (activated) (recombinant human protein C, rhAPC) reduces host coagulopathy response in patients with severe sepsis".
    Taylor F
    Thromb Haemost; 2003 Oct; 90(4):560-1. PubMed ID: 14515171
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of activated protein C (drotrecogin alfa) in a patient with sepsis and respiratory failure on ultra high frequency jet ventilation.
    Datta D; McNamee M
    Conn Med; 2003 Jan; 67(1):11-2. PubMed ID: 12630184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Re-administration of drotrecogin alpha].
    Romero B; García-Martínez MA; Solera M; Alvarez B
    Med Intensiva; 2009; 33(5):261-2. PubMed ID: 19625004
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment: obese man treated with drotrecogin alfa (activated).
    Small DS; Levy H
    Ann Pharmacother; 2004 Apr; 38(4):722-3; author reply 723. PubMed ID: 14990780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.